Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma

Sunil R.A.; Devang Bhavsar; Shruthi M.N.; U. Suryanarayan Kunikullaya; Vyas R.K.; Ankita Parikh; Maitrik Jayantkumar Mehta; Pooja Nandwani Patel

doi:10.5114/jcb.2018.75595

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

2/2018
vol. 10

Send email

Copy url:

abstract:

Original paper

Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma

Sunil R.A.

,

Devang Bhavsar

,

Shruthi M.N.

,

U. Suryanarayan Kunikullaya

,

Vyas R.K.

,

Ankita Parikh

,

Maitrik Jayantkumar Mehta

,

Pooja Nandwani Patel

J Contemp Brachytherapy 2018; 10, 2: 105–114

DOI: https://doi.org/10.5114/jcb.2018.75595

Online publish date: 2018/04/30

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

R.A. S, Bhavsar D, M.N. S, et al. Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma. Journal of Contemporary Brachytherapy. 2018;10(2):105-114. doi:10.5114/jcb.2018.75595.

APA

R.A., S., Bhavsar, D., M.N., S., Kunikullaya, U., R.K., V.,  & Parikh, A. et al. (2018). Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma. Journal of Contemporary Brachytherapy, 10(2), 105-114. https://doi.org/10.5114/jcb.2018.75595

Chicago

R.A., Sunil, Devang Bhavsar, Shruthi M.N., U. Suryanarayan Kunikullaya, Vyas R.K., Ankita Parikh,  and Maitrik Jayantkumar Mehta et al. 2018. "Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma". Journal of Contemporary Brachytherapy 10 (2): 105-114. doi:10.5114/jcb.2018.75595.

Harvard

R.A., S., Bhavsar, D., M.N., S., Kunikullaya, U., R.K., V., Parikh, A., Mehta, M.,  and Patel, P. (2018). Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma. Journal of Contemporary Brachytherapy, 10(2), pp.105-114. https://doi.org/10.5114/jcb.2018.75595

MLA

R.A., Sunil et al. "Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma." Journal of Contemporary Brachytherapy, vol. 10, no. 2, 2018, pp. 105-114. doi:10.5114/jcb.2018.75595.

Vancouver

R.A. S, Bhavsar D, M.N. S, Kunikullaya U, R.K. V, Parikh A et al. Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma. Journal of Contemporary Brachytherapy. 2018;10(2):105-114. doi:10.5114/jcb.2018.75595.

Purpose
Randomized trials on the effect of external beam radiotherapy (EBRT) with or without vaginal brachytherapy (VBT) for endometrial carcinoma are very few. In view of this, the current study was conducted with the hypothesizes: whether the escalated dose of 26 Gy (VBT alone) in comparison with various major international trials (PORTEC-2) has any difference in rates of disease-free and overall survival with fewer adverse effects in low resource setting like India.

Material and methods
An open-labeled, non-inferiority, randomized control trial was undertaken at a regional cancer center among patients with stage IA or IB high-intermediate risk endometrial carcinoma. A total of 50 patients were divided equally among two arms of combined EBRT with VBT (arm I) and VBT alone (arm II). A dose of 50-50.4 Gy in 25-28 fractions of EBRT with 2 fractions of VBT 6.5 Gy each were delivered to patients in arm I and 4 fractions of VBT 6.5 Gy each to patients in arm II, and were followed up for 60 months.

Results
During the median follow-up of 36.5 months, two patients developed loco-regional recurrence in arm II, three (arm II), and one (arm I) developed distant metastasis. The 5-year survival rates for arms I and II were 96.0% vs. 92.0% overall, and 88.0% vs. 84.0% disease-free, respectively, and were not found to be statistically significantly different. Dermatological, gastro-intestinal toxicities, and cystitis were lower in the VBT group compared to combined group.

Conclusions
VBT alone is as effective as EBRT+VBT in ensuring loco-regional control and achieving comparable survival rates, with fewer toxic effects for patients with stage I intermediate- and high-risk endometrial carcinoma. The dose escalation did not make a difference in the survival rates and was like in the other major trials (PORTEC-2).

keywords:

Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma

Sunil R.A. , Devang Bhavsar , Shruthi M.N. , U. Suryanarayan Kunikullaya , Vyas R.K. , Ankita Parikh , Maitrik Jayantkumar Mehta , Pooja Nandwani Patel

endometrial cancer, EBRT, vaginal brachytherapy

Sunil R.A.

,

Devang Bhavsar

,

Shruthi M.N.

,

U. Suryanarayan Kunikullaya

,

Vyas R.K.

,

Ankita Parikh

,

Maitrik Jayantkumar Mehta

,

Pooja Nandwani Patel